.On the heels of an FDA being rejected for its own main rivalrous Novo Nordisk, Eli Lilly is gaining...
.Merely a few months after application the 1st person in a period 2 trial for recently diagnosed gli...
.Eli Lilly's search for excessive weight aim ats has led it to the darker genome. The Big Pharma has...
.Toolbox Biosciences is carrying on up. The tissue treatment business has added on $325 million in a...
.After increasing $170 thousand back in February, metabolic disease-focused BioAge Labs has actually...
.Genentech is going to shut its cancer immunology analysis division, and unit head and also renowned...
.Kezar Lifestyle Sciences is losing its dim period 1 solid lump medication as the biotech goes all-i...
.In spite of izokibep preserving its newly found winning streak in the clinic, Acelyrin is no longer...
.Rivus Pharmaceuticals has plumped up the customers of its own fat-busting, muscle-sparing drug cand...
.Ovid Therapeutics already revealed final month that it was trimming back its own head count as the ...